July 31, 2025 a 05:00 pm
EMN: Analysts Ratings - Eastman Chemical Company
The Eastman Chemical Company operates across a diverse spectrum of markets with a specialization in specialty materials. With a strong presence in segments like Additives & Functional Products and Advanced Materials, the company's stock has garnered mixed sentiments from analysts. Despite a robust product offering, the company's recent ratings reflect a cautious optimism among analysts.
Historical Stock Grades
Recent analyst ratings for Eastman Chemical have shown a concentration in the 'Buy' category. This reflects a cautiously optimistic outlook from the analyst community.
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 10 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment development
The sentiment surrounding Eastman Chemical has displayed notable shifts over the months:
- The 'Buy' recommendation has sustained its dominance, showing consistent interest from analysts.
- 'Strong Buy' recommendations have decreased slightly since early 2025, indicating a tempered enthusiasm.
- 'Hold' positions have fluctuated, suggesting cautiousness as the year progresses.
- Overall analyst count has remained stable, indicating steady interest level.
Percentage trends
Examining percentage trends provides insight into categorical shifts:
- From a high percentage of 'Strong Buy' in mid-2024, there's a noticeable dip in early 2025.
- 'Buy' recommendations have remained consistent, reflecting sustained confidence in the stock.
- Minor fluctuations in 'Hold' indicate variable market sentiments.
- Long-term trends suggest increasing caution, with a slight decrease in overwhelmingly positive recommendations.
Latest Analyst Recommendations
Recent analyst recommendations show stability in rating assessments for Eastman Chemical:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-14 | Overweight | Overweight | Keybanc |
| 2025-07-09 | Buy | Buy | UBS |
| 2025-05-28 | Buy | Buy | UBS |
| 2025-04-29 | Equal Weight | Equal Weight | Barclays |
| 2025-04-28 | Overweight | Overweight | Keybanc |
Analyst Recommendations with Change of Opinion
Recent months have seen several noteworthy changes in analyst opinions:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-04-28 | Neutral | Overweight | JP Morgan |
| 2025-04-09 | Sector Outperform | Sector Perform | RBC Capital |
| 2025-04-04 | Buy | Neutral | Citigroup |
| 2025-04-03 | Outperform | Neutral | Mizuho |
| 2025-01-14 | Buy | Neutral | B of A Securities |
Interpretation
The stock of Eastman Chemical displays a stable outlook, although there is observable fluctuation in ratings over periods. The continuous rating stabilities suggest a steady confidence level in the company's market positioning. However, recent downgrades reveal minor emerging uncertainties, which require close monitoring. Analysts generally maintain a supportive stance, signaling assertion of consistency in its market strategies.
Conclusion
Eastman Chemical's rating trends suggest both opportunities and risks. While there is sustained Buy interest, recent downgrades hint at potential market concerns. The firm remains robust amidst current fluctuations, marking pivotal to monitor underlying strategic implementations. Overall, the outlook affirms both cautious optimism and an environment mindful of strategic shifts that could redefine sentiment directions moving forward.